Fig. 32.

⁶⁸Ga-PSMA, prostate cancer, biochemical recurrence (BCR): sensitivity. Clinical history: 72 y.o. man with prostate cancer, radical prostatectomy as primary treatment Gleason score 4 + 5; PSA = 0.4 ng/ml, PSA dt 6 months, TTR 10 months, candidate for salvage radiation therapy in the prostatic fossa. PET/CT findings: a focus of increased uptake is seen in the prostatic fossa and a right common iliac lymph node measuring 7 mm in maximum diameter. a MIP; b CT and fused images, local relapse; c CT and fused images, iliac lymph node